Literature DB >> 18452690

Q fever: epidemiology, diagnosis, and treatment.

Joshua D Hartzell1, Robert N Wood-Morris, Luis J Martinez, Richard F Trotta.   

Abstract

Q fever, a zoonosis caused by Coxiella burnetii, is seen throughout the world. Recent reports suggest that its incidence in the United States is increasing, with more than 30 cases reported in the US military. The disease has many acute and chronic manifestations. Endocarditis is the most common form of chronic disease, and recent studies have led to substantial changes in the approach to its diagnosis and treatment. Military and civilian health care professionals need to consider Q fever when evaluating patients with appropriate geographic exposures and clinical presentations to prevent delays in diagnosis and treatment.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18452690     DOI: 10.4065/83.5.574

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  24 in total

1.  65-year-old man with persistent fever.

Authors:  Zehra Haider; Constantine Tsigrelis; Larry M Baddour
Journal:  Mayo Clin Proc       Date:  2009-11       Impact factor: 7.616

2.  Q fever seroprevalence in metropolitan samples is similar to rural/remote samples in Queensland, Australia.

Authors:  S J Tozer; S B Lambert; T P Sloots; M D Nissen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-04-16       Impact factor: 3.267

3.  Coxiella burnetii infection of a Steller sea lion (Eumetopias jubatus) found in Washington State.

Authors:  Gilbert J Kersh; Dyanna M Lambourn; Joshua S Self; Adrianne M Akmajian; James B Stanton; Timothy V Baszler; Stephen A Raverty; Robert F Massung
Journal:  J Clin Microbiol       Date:  2010-06-30       Impact factor: 5.948

Review 4.  Community-acquired pneumonia related to intracellular pathogens.

Authors:  Catia Cillóniz; Antoni Torres; Michael Niederman; Menno van der Eerden; James Chalmers; Tobias Welte; Francesco Blasi
Journal:  Intensive Care Med       Date:  2016-06-08       Impact factor: 17.440

5.  Serological follow-up in patients with aorto-iliac disease and evidence of Q fever infection.

Authors:  J C J P Hagenaars; N H M Renders; A S van Petersen; S O A Shamelian; M G L de Jager-Leclercq; F L Moll; P C Wever; O H J Koning
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-03-12       Impact factor: 3.267

Review 6.  Coxiella burnetii: international pathogen of mystery.

Authors:  Amanda L Dragan; Daniel E Voth
Journal:  Microbes Infect       Date:  2019-09-28       Impact factor: 2.700

7.  Characterization of a lipopolysaccharide-targeted monoclonal antibody and its variable fragments as candidates for prophylaxis against the obligate intracellular bacterial pathogen Coxiella burnetii.

Authors:  Ying Peng; Laura Schoenlaub; Alexandra Elliott; William J Mitchell; Guoquan Zhang
Journal:  Infect Immun       Date:  2014-08-11       Impact factor: 3.441

8.  Acute Q fever in Portugal. Epidemiological and clinical features of 32 hospitalized patients.

Authors:  Carolina Palmela; Robert Badura; Emília Valadas
Journal:  Germs       Date:  2012-06-01

9.  Cost-effectiveness of a screening strategy for Q fever among pregnant women in risk areas: a clustered randomized controlled trial.

Authors:  Janna M Munster; Alexander C A P Leenders; Wim van der Hoek; Peter M Schneeberger; Ariene Rietveld; Josien Riphagen-Dalhuisen; Ronald P Stolk; Carl J C M Hamilton; Esther de Vries; Jamie Meekelenkamp; Jerome R Lo-Ten-Foe; Albertus Timmer; Lolkje T W De Jong-van den Berg; Jan G Aarnoudse; Eelko Hak
Journal:  BMC Womens Health       Date:  2010-11-01       Impact factor: 2.809

10.  Presence and persistence of Coxiella burnetii in the environments of goat farms associated with a Q fever outbreak.

Authors:  Gilbert J Kersh; Kelly A Fitzpatrick; Joshua S Self; Rachael A Priestley; Aubree J Kelly; R Ryan Lash; Nicola Marsden-Haug; Randall J Nett; Adam Bjork; Robert F Massung; Alicia D Anderson
Journal:  Appl Environ Microbiol       Date:  2013-01-11       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.